home

NVCR.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
NVCR
US
Novocure Ltd

Market global news for NVCR (US) Novocure Ltd

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
NovoCure Limited (NASDAQ:NVCR) Shares Purchased by C WorldWide Group Holding A S
modernreaders - 21:45 Sat - NVCR - link story
previous days
NovoCure Limited (NASDAQ:NVCR) Shares Purchased by C WorldWide Group Holding A S
modernreaders - 21:45 Sat 27 - NVCR - link story
Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
marketscreener - 15:15 Wed 24 - NVCR - link story
NovoCure : Corporate responsibility report
marketscreener - 17:30 Mon 22 - NVCR - link story
NovoCure (NASDAQ:NVCR) Stock Rating Reaffirmed by Piper Sandler
wkrb13 - 09:00 Sun 14 - NVCR - link story
NovoCure (NASDAQ:NVCR) Stock Rating Reaffirmed by Piper Sandler
theenterpriseleader - 09:00 Sun 14 - NVCR - link story
NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by Analysts
themarketsdaily - 11:30 Fri 12 - NVCR - link story
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
tickerreport - 08:30 Wed 10 - NVCR - link story
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
dailypolitical - 08:15 Wed 10 - NVCR - link story
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
wallstreet-online de - 12:15 Fri 5 - NVCR - link story
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
marketscreener - 11:30 Fri 5 - NVCR - link story
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
insidermonkey - 17:15 Thu 4 - NVCR - link story
Head to Head Contrast: Minerva Surgical (NASDAQ:UTRS) and NovoCure (NASDAQ:NVCR)
wkrb13 - 08:45 Tue 2 - NVCR - link story
Novocure to Report First Quarter 2024 Financial Results
wallstreet-online de - 12:00 Mon 1 - NVCR - link story
Novocure to Report First Quarter 2024 Financial Results
yahoo - 11:30 Mon 1 - NVCR - link story
NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush
dailypolitical - 08:30 Sun 31 - NVCR - link story
NovoCure (NASDAQ:NVCR) Price Target Raised to $24.00 at HC Wainwright
theenterpriseleader - 08:00 Sun 31 - NVCR - link story
Why NovoCure Stock Soared 18.3% This Week
fool - 13:00 Sat 30 - NVCR - link story
Why NovoCure Stock Soared 18.3% This Week
yahoo - 12:30 Sat 30 - NVCR - link story
NovoCure (NASDAQ:NVCR) Earns "Neutral" Rating from Wedbush
theenterpriseleader - 08:15 Sat 30 - NVCR - link story
Why Novocure Stock Is Jumping Today
yahoo - 16:45 Thu 28 - NVCR - link story
Why Novocure Stock Is Jumping Today | The Motley Fool
fool - 16:15 Thu 28 - NVCR - link story
NovoCure (NASDAQ:NVCR) Trading Up 4.8% Following Analyst Upgrade
themarketsdaily - 15:00 Thu 28 - NVCR - link story
Novocure's Electrical Cancer Therapy Shows It Can Treat Tumors in the Brain
medcitynews - 02:15 Thu 28 - NVCR - link story
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights - NovoCure (NASDAQ:NVCR)
benzinga - 21:15 Wed 27 - NVCR - link story
Novocure's stock surges after positive results in brain-cancer trial
biztoc - 21:00 Wed 27 - NVCR - link story
Novocure device slows spread of lung cancer to brain in late-stage study
proactiveinvestors - 16:30 Wed 27 - NVCR - link story
Novocure Stock Soars After Wearable Device Shows Promise In Brain Tumors
investors - 15:45 Wed 27 - NVCR - link story
Why Is Novocure Stock Trading Higher On Wednesday?
biztoc - 15:45 Wed 27 - NVCR - link story
Sector Update: Health Care -March 27, 2024 at 09:09 am EDT
marketscreener - 15:15 Wed 27 - NVCR - link story
Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment
biztoc - 15:15 Wed 27 - NVCR - link story
Novocure's lung cancer therapy succeeds in late-stage trial
kelo - 14:30 Wed 27 - NVCR - link story
Novocure (NVCR) shares jump after trial meets primary endpoint
streetinsider - 14:30 Wed 27 - NVCR - link story
Novocure's lung cancer device slows progression to brain in trial, shares rise
saltwire - 13:45 Wed 27 - NVCR - link story
Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
finanznachrichten de - 11:30 Wed 27 - NVCR - link story
Novocure (NVCR) Reports Phase 3 METIS Trial Met Primary Endpoint
streetinsider - 11:30 Wed 27 - NVCR - link story
NovoCure (NASDAQ:NVCR) Price Target Raised to $17.00
tickerreport - 15:00 Wed 20 - NVCR - link story
NovoCure (NASDAQ:NVCR) Price Target Raised to $17.00
wkrb13 - 15:00 Wed 20 - NVCR - link story